Publications of Andreas Roidl

Oak, P. S.; Kopp, F.; Thakur, C.; Ellwart, J. W.; Rapp, U. R.; Ullrich, A.; Wagner, E.; Knyazev, P.; Roidl, A.: Combinatorial treatment of mammospheres with trastuzumab and salinomycin efficiently targets HER2-positive cancer cells and cancer stem cells. INTERNATIONAL JOURNAL OF CANCER 131 (12), pp. 2808 - 2819 (2012)

Roidl, A.; Foo, P.; Wong, W.; Mann, C.; Bechtold, S.; Berger, H. J.; Streit, S.; Ruhe, J. E.; Hart, S.; Ullrich, A. et al.; Ho, H. K.: The FGFR4 Y367C mutant is a dominant oncogene in MDA-MB453 breast cancer cells. Oncogene 29 (10), pp. 1543 - 1552 (2010)

Roidl, A.; Berger, H. J.; Kumar, S.; Bange, J.; Knyazev, P.; Ullrich, A.: Resistance to Chemotherapy Is Associated with Fibroblast Growth Factor Receptor 4 Up-Regulation. Clinical Cancer Research 15 (6), pp. 2058 - 2066 (2009)

Roidl, A.: "Functional Genomics": Analyse antiapoptotischer Signalwege in Krebszellen. Dissertation, Ludwig-Maximilians-Universität, München (2007)